Cellino Hosts Second Annual Personalized RegenMed Forum to Accelerate Progress in Regenerative Medicine [Yahoo! Finance]
Nevro Corp. (NVRO)
Last nevro corp. earnings: 2/25 04:10 pm
Check Earnings Report
US:NYSE Investor Relations:
nevro.com/english/investors/overview/default.aspx
Company Research
Source: Yahoo! Finance
to maximize patient benefit. (Source: 'Under the theme "Catalyze," the Forum focused on accelerating the development of regenerative medicines and adopting new technologies to maximize patient benefit.') Some of the prominent speakers included Susan Hockfield, Ph.D., President Emerita of Massachusetts Institute of Technology; Vinod Khosla, Founder of Khosla Ventures; and Sue Siegel, Board Member of Align, Nevro, Illumina, KFF, and Chairman of the Board of The Engine Accelerator. (Source: 'The Forum featured prominent speakers including...') The spotlight sessions showcased research from leading organizations including Trestle Biotherapeutics, Karis Bio, and Massachusetts Eye and Ear, which are developing regenerative therapies addressing kidney disease, peripheral artery disease, and glaucoma. (Source: 'Spotlight sessions showcased research from leading organizations...') The Forum featured a discussion with Vinod Khosla on leveraging AI to democratize wide patient access to pot
Show less
Read more
Impact Snapshot
Event Time:
NVRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVRO alerts
High impacting Nevro Corp. news events
Weekly update
A roundup of the hottest topics
NVRO
News
- Nevro Corp. (NYSE: NVRO) had its price target lowered by analysts at Truist Financial Co. from $7.00 to $4.70. They now have a "hold" rating on the stock.MarketBeat
- Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 [Yahoo! Finance]Yahoo! Finance
- Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08PR Newswire
- Here's Why you Should Retain Nevro Stock in Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- Nevro Corp. (NYSE: NVRO) had its price target lowered by analysts at Citigroup Inc. from $6.00 to $5.00. They now have a "neutral" rating on the stock.MarketBeat
NVRO
Earnings
- 11/11/24 - Beat
NVRO
Sec Filings
- 12/20/24 - Form 4
- 12/9/24 - Form 4
- 12/9/24 - Form 4
- NVRO's page on the SEC website